APPLICATIONS PUBLISHED 15 DECEMBER 2004

Published: 14-Dec-2005

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Sodium channel blockers
    Johnson, Michael 1485359*

  • Sodium channel blockers
    Johnson, Michael 1485360*

  • Amphoteric and cationic fluorescent whitening agents
    Ciba Specialty Chemicals 1485361*

  • Crystalline parecoxib sodium
    Pharmacia 1485362*

  • Cyclic amides
    Merck 1485363*

  • Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
    Janssen Pharmaceutica 1485364*

  • Sulphonyl derivatives as novel inhibitors of histone deacetylase
    Janssen Pharmaceutica 1485365*

  • Process for the epoxidation of olefins
    Degussa 1485366*

  • Purified citalopram salts
    Cipla 1485367*

  • Substituted chroman derivatives having cytochrome P450RAI inhibitory activity
    Allergan 1485368*

  • Blue 3H-naphtho-2,1B]-pyran derivatives and use thereof
    Rodenstock 1485369*

  • Amino-derivatives as novel inhibitors of inhibitors of histone deacetylase
    Janssen Pharmaceutica 1485370*

  • Indole amide derivatives and their use as glycogen phosphorylase inhibitors
    AstraZeneca 1485371*

  • Bicyclic fused pyridinyl amides and advantageous compsns
    E I duPont de Nemours 1485372*

  • Method of stabilising lansoprazole
    Teva Pharmaceutical Industries 1485373*

  • Pyrimidine compounds
    AstraZeneca 1485374*

  • Pyrimidine compounds
    AstraZeneca 1485375*

  • Compsns useful as inhibitors of protein kinases
    Vertex Pharmaceuticals; Binch, Hayley 1485376*

  • Pyranones useful as ATM inhibitors
    Kudos Pharmaceuticals 1485377*

  • Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
    Janssen Pharmaceutica 1485378*

  • Beta 3-adrenergic receptor agonists
    Pfizer Products 1485379*

  • Azolylaminoazides as inhibitors of protein kinases
    Vertex Pharmaceuticals 1485380*

  • Azolylaminoazides as inhibitors of protein kinases
    Vertex Pharmaceuticals; Bebbington, David; Binch, Hayley; Charrier, Jean-Damien; Everitt, Simon; Golec, Julian 1485381*

  • Process for the synthesis of pergolide
    Antibioticos 1485382*

  • Process for preparing crystalline form 1 of cabergoline
    Pharmacia 1485383*

  • Pyrazolo(1,5-A)pyridine derivatives as neurotransmitter modulators
    Pharmacia & Upjohn 1485384*

  • Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compsns containing them
    SmithKline Beecham 1485385*

  • Pyridinyloxy derivatives as 5-HT receptor ligands
    Pharmacia & Upjohn 1485386*

  • Carbamates as HIV-protease inhibitors
    Board of Trustees of the University of Illinois 1485387*

  • Topiramate salts and compsns comprising and methods of making and using the same
    Ortho-McNeil Pharmaceuticals 1485388*

  • Antiparasitic artemisinin derivatives (endoperoxides)
    Bayer Business Services 1485389*

  • Bicyclic pyridine and pyrimidine P38 kinase inhibitors
    F Hoffmann-La Roche 1485390*

  • Phosphate transport inhibitors
    Genzyme 1485391*

  • Bisphosphite ligands for carbonylation processes
    Union Carbide Chemicals & Plastics Technology 1485392*

  • 9-dexo-9A-aza-9A-methyl-9A-homoerythromycin A derivatives
    Pilva - Istrazivacki Institut 1485393*

  • Process for isolation of eupalitin (3-O-beta-D-galactopyranoside) from Boerhavia diffusa
    Council of Scientific and Industrial Research 1485394*

  • Nucleotide mimics and their prodrugs
    Biota 1485395*

  • Nucleoside 5'-monophosphate mimics and their prodrugs
    Biota 1485396*

  • Trans-splicing mediated imaging of gene expression
    Intronn 1485397*

  • Methods of screening for compounds that modulate hormone receptor activity
    Allergan 1485398*

  • Methods of analysing methylated CPG islands and GC rich regions
    The Johns Hopkins University 1485399*

  • Human rinase II and compsns and uses thereof
    Isis Pharmaceuticals 1485400*

  • TRPM-2 antisense therapy using an oligonucleotide having 2'-O-(2-methoxyl)ethyl modifications
    The University of British Columbia 1485401*

  • Selective extraction of DNA from groups of cells
    Choicepoint Asset Company 1485402*

  • Compsns and methods to initiate or enhance antibody and major histocompatibility class I or class II-restricted T-cell responses by using immunomodulatory, non-coding RNA motifs
    Astral 1485403*

  • Novel glucose 6-oxidases
    California Institute of Technology 1485404*

  • Melanin-concentrating hormone analogues
    Merck 1485405*

  • Highly homogeneous molecular markers for electrophoresis
    Invitrogen 1485406*

  • A mutated immunoglobulin-binding protein
    Amersham Biosciences 1485407*

  • Mutagenesis of Aspergillus fungi and genes essential for growth
    Bayer CropScience 1485408*

  • Compsns isolated from bovine mammary gland and methods for their use
    Genesis Research & Development Corp 1485409*

  • Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
    Evotec Neurosciences 1485410*

  • Arrays of cytosolic accessory proteins immobilised on a surface
    Sense Proteomic 1485411*

  • Repressor of skeletal muscle differentiation, nucleic acids coding thereof and the use thereof in diagnosis and therapy
    Universitatsklinikum Freiburg 1485412*

  • Biologically active complex
    Svanborg, Catharina 1485413*

  • A multifunctional complex for targeting specific phagocytosis of a target agent
    Yamit Biotechnologies 1485414*

  • Neoplasm specific antibodies and uses thereof
    Oncomab 1485415*

  • Protein biomarkers that distinguish prostate cancer from non-malignant cells
    Eastern Virginia Medical School 1485461*

  • Secondary metabolite cogener distribution modulation
    Kosan Biosciences 1485462*

  • Lactobacillus strains
    Bifodan 1485463*

  • Methods of inducing differentiation in ex vivo expanded stem cells
    Gamida Cell 1485464*

  • Microcapillary bioreactor for growth of biological tissue
    Arizona Board of Regents 1485465*

  • Methods for treating diseases or conditions with peptide constructs
    Cel-Sci Corp 1485466*

  • You may also like